CLPT logo

ClearPoint Neuro (CLPT) EBITDA

Annual EBITDA

-$20.99 M
-$5.41 M-34.74%

December 31, 2023


Summary


Performance

CLPT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLPTprofitabilitymetrics:

Quarterly EBITDA

-$4.68 M
-$401.00 K-9.38%

September 30, 2024


Summary


Performance

CLPT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLPTprofitabilitymetrics:

TTM EBITDA

-$16.99 M
-$203.00 K-1.21%

September 30, 2024


Summary


Performance

CLPT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLPTprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CLPT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-34.7%-4.5%+19.3%
3 y3 years-338.4%-31.4%-69.7%
5 y5 years-313.7%-451.2%-292.1%

CLPT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-64.7%at low-29.0%+31.1%-33.3%+19.3%
5 y5-year-384.3%at low-335.9%+31.1%-292.1%+19.3%
alltimeall time-632.4%at low-262.7%+31.1%-1055.3%+19.3%

ClearPoint Neuro EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.68 M(+9.4%)
-$16.99 M(+1.2%)
Jun 2024
-
-$4.28 M(+13.8%)
-$16.79 M(-13.0%)
Mar 2024
-
-$3.76 M(-12.3%)
-$19.30 M(-8.0%)
Dec 2023
-$20.99 M(+34.7%)
-$4.28 M(-4.3%)
-$20.99 M(-0.3%)
Sep 2023
-
-$4.47 M(-34.1%)
-$21.05 M(+4.2%)
Jun 2023
-
-$6.79 M(+24.8%)
-$20.20 M(+16.2%)
Mar 2023
-
-$5.44 M(+25.4%)
-$17.37 M(+11.5%)
Dec 2022
-$15.58 M(+22.2%)
-$4.34 M(+19.7%)
-$15.58 M(+3.5%)
Sep 2022
-
-$3.63 M(-8.7%)
-$15.04 M(+0.4%)
Jun 2022
-
-$3.97 M(+8.9%)
-$14.98 M(+4.5%)
Mar 2022
-
-$3.65 M(-4.2%)
-$14.33 M(+12.5%)
Dec 2021
-$12.74 M(+166.2%)
-$3.81 M(+7.0%)
-$12.74 M(+27.3%)
Sep 2021
-
-$3.56 M(+7.1%)
-$10.01 M(+30.7%)
Jun 2021
-
-$3.32 M(+61.4%)
-$7.66 M(+34.0%)
Mar 2021
-
-$2.06 M(+91.8%)
-$5.72 M(+19.4%)
Dec 2020
-$4.79 M(+10.5%)
-$1.07 M(-10.9%)
-$4.79 M(-5.4%)
Sep 2020
-
-$1.20 M(-12.8%)
-$5.06 M(+7.6%)
Jun 2020
-
-$1.38 M(+22.2%)
-$4.71 M(+3.3%)
Mar 2020
-
-$1.13 M(-16.2%)
-$4.56 M(+5.2%)
Dec 2019
-$4.33 M(-14.6%)
-$1.35 M(+58.9%)
-$4.33 M(+10.1%)
Sep 2019
-
-$848.50 K(-31.1%)
-$3.94 M(-7.2%)
Jun 2019
-
-$1.23 M(+35.8%)
-$4.24 M(-8.1%)
Mar 2019
-
-$906.30 K(-4.8%)
-$4.62 M(-9.0%)
Dec 2018
-$5.07 M(-17.9%)
-$951.70 K(-17.6%)
-$5.07 M(-14.6%)
Sep 2018
-
-$1.16 M(-28.0%)
-$5.94 M(-0.5%)
Jun 2018
-
-$1.60 M(+17.8%)
-$5.98 M(-2.6%)
Mar 2018
-
-$1.36 M(-25.3%)
-$6.13 M(-0.7%)
DateAnnualQuarterlyTTM
Dec 2017
-$6.18 M(-10.0%)
-$1.82 M(+53.5%)
-$6.18 M(+6.7%)
Sep 2017
-
-$1.19 M(-32.6%)
-$5.79 M(-16.0%)
Jun 2017
-
-$1.76 M(+25.3%)
-$6.89 M(+4.2%)
Mar 2017
-
-$1.41 M(-2.0%)
-$6.61 M(-3.7%)
Dec 2016
-$6.86 M(-1.6%)
-$1.44 M(-37.2%)
-$6.86 M(+10.0%)
Sep 2016
-
-$2.29 M(+54.2%)
-$6.24 M(+61.4%)
Jun 2016
-
-$1.48 M(-10.5%)
-$3.87 M(-23.9%)
Mar 2016
-
-$1.66 M(+103.7%)
-$5.08 M(-27.1%)
Dec 2015
-$6.97 M(+122.9%)
-$813.70 K(-1029.9%)
-$6.97 M(-9.4%)
Sep 2015
-
$87.50 K(-103.2%)
-$7.70 M(-30.4%)
Jun 2015
-
-$2.70 M(-24.0%)
-$11.06 M(+15.7%)
Mar 2015
-
-$3.55 M(+131.0%)
-$9.55 M(+205.4%)
Dec 2014
-$3.13 M(-49.2%)
-$1.54 M(-53.0%)
-$3.13 M(+1.2%)
Sep 2014
-
-$3.27 M(+173.4%)
-$3.09 M(+11.5%)
Jun 2014
-
-$1.20 M(-141.6%)
-$2.77 M(+3.4%)
Mar 2014
-
$2.87 M(-291.7%)
-$2.68 M(-56.5%)
Dec 2013
-$6.16 M(+115.0%)
-$1.50 M(-49.2%)
-$6.16 M(+75.6%)
Sep 2013
-
-$2.95 M(+167.1%)
-$3.51 M(+11.9%)
Jun 2013
-
-$1.11 M(+83.2%)
-$3.13 M(+29.6%)
Mar 2013
-
-$603.50 K(-152.4%)
-$2.42 M(-15.6%)
Dec 2012
-$2.87 M(-47.5%)
$1.15 M(-144.7%)
-$2.87 M(-45.1%)
Sep 2012
-
-$2.58 M(+561.2%)
-$5.22 M(+46.3%)
Jun 2012
-
-$389.90 K(-62.9%)
-$3.57 M(-23.2%)
Mar 2012
-
-$1.05 M(-12.8%)
-$4.65 M(+29.2%)
Dec 2011
-$5.46 M(-28.2%)
-$1.20 M(+30.2%)
-$3.60 M(+50.3%)
Sep 2011
-
-$925.00 K(-37.1%)
-$2.40 M(+62.9%)
Jun 2011
-
-$1.47 M
-$1.47 M
Dec 2010
-$7.60 M
-
-

FAQ

  • What is ClearPoint Neuro annual EBITDA?
  • What is the all time high annual EBITDA for ClearPoint Neuro?
  • What is ClearPoint Neuro annual EBITDA year-on-year change?
  • What is ClearPoint Neuro quarterly EBITDA?
  • What is the all time high quarterly EBITDA for ClearPoint Neuro?
  • What is ClearPoint Neuro quarterly EBITDA year-on-year change?
  • What is ClearPoint Neuro TTM EBITDA?
  • What is the all time high TTM EBITDA for ClearPoint Neuro?
  • What is ClearPoint Neuro TTM EBITDA year-on-year change?

What is ClearPoint Neuro annual EBITDA?

The current annual EBITDA of CLPT is -$20.99 M

What is the all time high annual EBITDA for ClearPoint Neuro?

ClearPoint Neuro all-time high annual EBITDA is -$2.87 M

What is ClearPoint Neuro annual EBITDA year-on-year change?

Over the past year, CLPT annual EBITDA has changed by -$5.41 M (-34.74%)

What is ClearPoint Neuro quarterly EBITDA?

The current quarterly EBITDA of CLPT is -$4.68 M

What is the all time high quarterly EBITDA for ClearPoint Neuro?

ClearPoint Neuro all-time high quarterly EBITDA is $2.87 M

What is ClearPoint Neuro quarterly EBITDA year-on-year change?

Over the past year, CLPT quarterly EBITDA has changed by -$203.00 K (-4.54%)

What is ClearPoint Neuro TTM EBITDA?

The current TTM EBITDA of CLPT is -$16.99 M

What is the all time high TTM EBITDA for ClearPoint Neuro?

ClearPoint Neuro all-time high TTM EBITDA is -$1.47 M

What is ClearPoint Neuro TTM EBITDA year-on-year change?

Over the past year, CLPT TTM EBITDA has changed by +$4.05 M (+19.26%)